Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches

Pharmacological Research

Volumn 63, Issue 3, 2011, Pages 216-224

  Premaud A ^a,b   Weber, L T ^c   Tonshoff B ^d   Armstrong, V W ^e   Oellerich, M ^e   Urien, S ^f   Marquet, P ^a,b,g   Rousseau, A ^a,b  

^a Univ Limoges   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^f INSERM   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

Mycophenolic acid; Nonparametric; Parametric; Pediatric; Population pharmacokinetics; Renal transplantation

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ARTICLE; BAYES THEOREM; CHILD; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXPOSURE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; NONLINEAR MIXED EFFECT MODELING; NONLINEAR SYSTEM; NONPARAMETRIC ADAPTIVE GRID; NONPARAMETRIC TEST; OUTCOME ASSESSMENT; PARAMETRIC TEST; PEDIATRIC SURGERY; PEDIATRICS; POPULATION DYNAMICS; POPULATION MODEL; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; INFANT; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; STATISTICS, NONPARAMETRIC;

EID: 79751533325     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2010.10.017     Document Type: Article

References (43)

1. B. Hocker, L.T. Weber, T. Buncman, M. Rashford, and B. Tonshoff Mycophenolate mofetil suspension in pediatric renal transplantation: three-year data from the tricontinental trial Pediatr Transplant 2005 504 511 (Pubitemid 41153272)
2. T. Jungraithmayr, A. Staskewitz, G. Kirste, M. Böswald, M. Bulla, and R. Burghard For the german pediatric renal transplantation study group. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years Transplantation 75 2003 454 461 (Pubitemid 36241138)
3. T. Bunchman, M. Navarro, M. Broyer, J. Sherbotie, B. Chavers, and B. Tönshoff The use of mycophenolate mofetil suspension in pediatric renal allograft recipients Pediatr Nephrol 16 2001 978 984 (Pubitemid 34026706)
4. A. Staskewitz, G. Kirste, B. Tonshoff, L.T. Weber, M. Boswald, and R. Burghard Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German pediatric renal transplantation study group Transplantation 71 2001 638 644 (Pubitemid 32268065)
5. L.T. Weber, M. Shipkova, V.W. Armstrong, N. Wagner, E. Schütz, and O. Mehls The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy J Am Soc Nephrol 13 2002 759 768 (Pubitemid 34183943)
6. L.T. Weber, T. Lamersdorf, M. Shipkova, P.D. Niedmann, M. Wiesel, and L.B. Zimmerhackl Area under the plasma concentration-time curve for total, but not for free, mycophenolic acid increases in the stable phase after renal transplantation: a longitudinal study in pediatric patients. German study group on mycophenolate mofetil therapy in pediatric renal transplant recipients Ther Drug Monit 21 1999 498 506 (Pubitemid 29468315)
7. L.T. Weber, M. Shipkova, V.W. Armstrong, N. Wagner, E. Schütz, and O. Mehls The pharmacokinetic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy J Am Soc Nephrol 13 2002 759 768 (Pubitemid 34183943)
8. L.T. Weber, B. Hoecker, V.W. Armstrong, M. Oellerich, and B. Tönshoff Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3 years posttransplant Ther Drug Monit 30 2008 570 575
9. R.M. van Hest, T. van Gelder, R. Bouw, T. Goggin, R. Gordon, and R.D. Mamelok Time-dependent clearance of mycophenolic acid in renal transplant recipients Br J Clin Pharmacol 63 6 2007 741 752 (Pubitemid 46753575)
10. Y. Le Meur, M. Büchler, A. Thierry, S. Caillard, F. Villemain, and S. Lavaud Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation Am J Transplant 7 2007 2496 2503 (Pubitemid 47566324)
11. M. Oellerich, M. Shipkova, E. Schutz, E. Wieland, L.T. Weber, and B. Tonshoff Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German study group on mycophenolate mofetil therapy in pediatric renal transplant recipients Ther Drug Monit 22 2000 20 26 (Pubitemid 30083090)
12. A. Prémaud, J. Debord, A. Rousseau, Y. Le Meur, O. Toupance, and Y. Lebranchu A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil Clin Pharmacokinet 44 8 2005 837 847 (Pubitemid 41126931)
13. B.C. de Winter, T. van Gelder, F. Sombogaard, L.M. Shaw, R.M. van Hest, and R.A. Mathot Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients J Pharmacokinet Pharmacodyn 36 6 2009 541 564
14. Z. Jiao, J.J. Ding, J. Shen, H.Q. Liang, L.J. Zhong, and Y. Wang Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9 Br J Clin Pharmacol 65 6 2008 893 907 (Pubitemid 351677427)
15. B. Shum, S.B. Duffull, P.J. Taylor, and S.E. Tett Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil Br J Clin Pharmacol 56 2003 188 197 (Pubitemid 36981434)
16. T. Funaki Enterohepatic circulation model for population pharmacokinetic analysis J Pharm Pharmacol 51 10 1999 1143 1148 (Pubitemid 29520460)
17. F.T. Musuamba, A. Rousseau, J.L. Bosmans, J.J. Senessael, J. Cumps, and P. Marquet Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus Clin Pharmacokinet 48 11 2009 745 758
18. L.T. Weber, B. Hoecker, V.W. Armstrong, M. Oellerich, and B. Tönshoff Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients Ther Drug Monit 28 2006 623 631 (Pubitemid 44564060)
19. G. Filler, and I. Mai Limited sampling strategy for mycophenolic acid area under the curve Ther Drug Monit 22 2000 169 173 (Pubitemid 30196820)
20. E. Schütz, V.W. Armstrong, M. Shipkova, L. Weber, P.D. Niedmann, and T. Lammersdorf Limited sampling strategy for the determination of mycophenolic acid area under the curve in pediatric kidney recipients Transplant Proc 30 1998 1182 1184 (Pubitemid 28309530)
21. A. Prémaud, Y. Le Meur, J. Debord, J.C. Szelag, A. Rousseau, and G. Hoizey Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods Ther Drug Monit 27 3 2005 354 361 (Pubitemid 40770993)
22. A. Prémaud, A. Rousseau, Y. Le Meur, N. Venisse, C. Loichot, and A. Turcant Feasibility of, and critical paths for mycophenolate mofetil Bayesian dose adjustment: pharmacological re-appraisal of a concentration-controlled versus fixed-dose trial in renal transplant recipients Pharmacol Res 61 2 2010 167 174
23. A. Rousseau, M.L. Laroche, N. Venisse, C. Loichot-Roselmac, A. Turcant, and G. Hoizey Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the apomygre trial Transplantation 2010 [Epub ahead of print]
24. S. Payen, D. Zhang, A. Maisin, M. Popon, A. Bensman, and F. Bouissou Population pharmacokinetics of mycophenolic acid in kidney transplant pediatric and adolescent patients Ther Drug Monit 27 2005 378 388 (Pubitemid 40770997)
25. C. Le Guellec, H. Bourgoin, M. Büchler, Y. Le Meur, Y. Lebranchu, and P. Marquet Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients Clin Pharmacokinet 43 2004 253 266 (Pubitemid 38429305)
26. C.E. Staatz, S.B. Duffull, B. Kiberd, A.D. Fraser, and S.E. Tett Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation Eur J Clin Pharmacol 61 7 2005 507 516 (Pubitemid 41218821)
27. R.M. van Hest, T. van Gelder, A.G. Vulto, and R.A. Mathot Population pharmacokinetics of mycophenolic acid in renal transplant recipients Clin Pharmacokinet 44 2005 1083 1096 (Pubitemid 41356393)
28. B.C. de Winter, T. van Gelder, P. Glander, D. Cattaneo, H. Tedesco-Silva, and I. Neumann Population pharmacokinetics of mycophenolic acid: a comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients Clin Pharmacokinet 47 12 2008 827 838
29. W.J. Sam, F. Akhlaghi, and S.E. Rosenbaum Population pharmacokinetics of mycophenolic acid and its 2 glucuronidated metabolites in kidney transplant recipients J Clin Pharmacol 49 2 2009 185 195
30. K.J. Petersson, E. Hanze, R.M. Savic, and M.O. Karlsson Semiparametric distributions with estimated shape parameters Pharm Res 26 9 2009 2174 2185
31. R. Leary, R. Jelliffe, A. Schumitzky, and M.A. Van Guilder Unified parametric/nonparametric approach to population PK/PD modeling Annual meeting of the Population Approach Group in Europe Paris, France, June 6-7 2002
32. A. Schumitzky The nonparametric maximum likelihood approach to pharmacokinetic population analysis Proceedings of the 1993 western simulation multiconference-simulation for health care Society for Computer Simulation 1993 95 100
33. A. Mallet A maximum likelihood estimation method for random coefficient regression moels Biometrika 73 1986 645 656
34. M. Shipkova, P.D. Niedmann, V.W. Armstrong, E. Schütz, E. Wieland, and L.M. Shaw Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure Clin Chem 44 1998 1481 1488 (Pubitemid 28309109)
35. S.L. Beal, L.B. Sheiner, and A. Boeckmann NONMEM user's guides 1989-2006 Icon Development Solutions Ellicott City, MD
36. U.S. Rfn R for Nonmen A graphical interface for Nonmen outputs 2009
37. M.O. Karlsson, and R.M. Savic Diagnosing model diagnostics Clin Pharmacol Ther 82 1 2007 17 20 (Pubitemid 46944205)
38. D.Z. D'Argenio, and A. Schumitzky ADAPT II User's guide. Pharmacokinetics/pharmacodynamic systems analysis software, biomedical simulations resource 1997 University of Southern California
39. R Development Core Team R: A language and environment for statistical computing 2009 R Foundation for Statistical Computing Vienna, Austria
40. W. Zhao, M. Fakhoury, G. Deschênes, G. Roussey, K. Brochard, and P. Niaudet Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients J Clin Pharmacol 69 4 2010 358 366
41. D.A. Hesselink, R.M. van Hest, and R.A.A. Mathot Cyclosporin interacts with mycophenolate mofetil by inhibiting the multidrug resistance-associated protein 2 Am J Transplant 5 2005 987 994 (Pubitemid 40571246)
42. T. Van Gelder, J. Klupp, M.J. Barten, U. Christians, and R.E. Morris Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid Ther Drug Monit 23 2001 119 128 (Pubitemid 32240138)
43. A. Bustad, D. Terziivanov, R. Leary, R. Port, A. Schumitzky, and R. Jelliffe Parametric and nonparametric population methods. Their comparative performance in analyzing a clinical dataset and two Monte Carlo simulation studies Clin Pharmacokinet 45 2006 365 383